Recruiting Sjogrens Syndrome Studies in Augusta
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome
The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome....
A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome
The purpose of this study is to measure the efficacy and safety of HZN-1116 in participants with Sjogren's syndrome (SS)....
About Sjogrens Syndrome Clinical Trials in Augusta
Sjogren's syndrome is a chronic autoimmune disorder in which the immune system attacks the glands that produce moisture, causing dry eyes and dry mouth. It can also affect joints, thyroid, kidneys, and other organs. Treatment focuses on relieving symptoms and may include immunosuppressive medications.
There are currently 2 sjogrens syndrome clinical trials recruiting participants in Augusta, GA. These studies are seeking a combined 1,018 participants. Research is being sponsored by Bristol-Myers Squibb, Amgen. Clinical trial participation is free and participants receive study-related medical care at no cost.
Sjogrens Syndrome Clinical Trials in Augusta — FAQ
Are there sjogrens syndrome clinical trials in Augusta?
Yes, there are 2 sjogrens syndrome clinical trials currently recruiting in Augusta, GA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Augusta?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Augusta research site will contact you about next steps.
Are clinical trials in Augusta free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Augusta studies also compensate for your time and travel.
What sjogrens syndrome treatments are being tested?
The 2 active trials in Augusta are testing new therapies including novel drugs, biologics, and treatment approaches for sjogrens syndrome.
Data updated March 2, 2026 from ClinicalTrials.gov